Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Cancer Research|June 26, 1999
Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptorG S Wu, T F Burns, Y Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Bypass of abnormal MDM2 inhibition of p53-dependent growth suppressionR D Meng, H Shih, N S Prabhu, et al.
Human Molecular Genetics|September 1, 1994
p53 tagged sites from human genomic DNAT Tokino, S Thiagalingam, W S el-Deiry, et al.
International Journal of Oncology|June 2, 2010
Anticancer activity of botanical compounds in ancient fermented beverages (review)P E McGovern, M Christofidou-Solomidou, W Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosisR D Meng, E R McDonald, M S Sheikh, et al.
The Journal of Biological Chemistry|March 30, 2001
Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signalingE R McDonald, P C Chui, P F Martelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
Sequence-specific transcriptional activation is essential for growth suppression by p53J A Pietenpol, T Tokino, S Thiagalingam, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 1996
Expression of p21waf1/Cip1, MDM2 and p53 in vivo: analysis of cytological preparationsS P Dowell, E McGoogan, S M Picksley, et al.
Cancer Research|March 14, 2001
Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikisG S Goldberg, Z Jin, H Ichikawa, et al.
Cancer Research|December 5, 2000
The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligandN Ozoren, K Kim, T F Burns, et al.
Pageof 9